In fact, it’s not even the first time that IBM has tried — unsuccessfully — to unload the project, in yet another sign that corporate expectations for AI are continuing to crash into reality.

“Health care always is going to turn out to be more subtle, as well as more regulated for the right reasons, than it is in other areas,” IBM CEO Arvind Krishna said in an Axios and HBO interview last year. “And to me, that’s natural. It is a decision that may impact somebody’s life or death. You got to be more careful. So in health care, it turns out maybe we were too optimistic.”

The sale, if it actually goes through this time, would affect millions of patients and entire government healthcare strategies.